Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Domenica Cappellini

Showing results (1-10 of 311) with videos related to

Pageof 32
Sort By:
Therapeutics and Clinical Risk Management|March 25, 2008
Exjade(R) (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusionMaria Domenica Cappellini
Hematology. American Society of Hematology. Education Program|November 21, 2007
Coagulation in the pathophysiology of hemolytic anemiasMaria Domenica Cappellini
Blood Reviews|December 17, 2008
Management of iron overload. IntroductionMaria Domenica Cappellini
Blood Reviews|December 17, 2008
Long-term efficacy and safety of deferasiroxMaria Domenica Cappellini
Seminars in Hematology|September 26, 2015
Anemia in Clinical Practice: IntroductionMaria-Domenica Cappellini, Photis Beris
European Journal of Internal Medicine|December 1, 2019
A new approach for anemia in kidney diseasePiergiorgio Messa, Maria Domenica Cappellini
Therapeutics and Clinical Risk Management|November 10, 2009
Update on the use of deferasirox in the management of iron overloadAli Taher, Maria Domenica Cappellini
Human Genetics|June 29, 2007
Gene symbol: HBDChiara Refaldi, Maria Domenica Cappellini
Annual Review of Medicine|July 28, 2009
Oral iron chelatorsMaria Domenica Cappellini, Paolo Pattoneri
Blood|September 13, 2018
How I manage medical complications of β-thalassemia in adultsAli T Taher, Maria Domenica Cappellini
Pageof 32

Showing results (1-10 of 311) with videos related to

Sort By:
Pageof 32
Therapeutics and Clinical Risk Management|March 25, 2008
Exjade(R) (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusionMaria Domenica Cappellini
Hematology. American Society of Hematology. Education Program|November 21, 2007
Coagulation in the pathophysiology of hemolytic anemiasMaria Domenica Cappellini
Blood Reviews|December 17, 2008
Management of iron overload. IntroductionMaria Domenica Cappellini
Blood Reviews|December 17, 2008
Long-term efficacy and safety of deferasiroxMaria Domenica Cappellini
Seminars in Hematology|September 26, 2015
Anemia in Clinical Practice: IntroductionMaria-Domenica Cappellini, Photis Beris
European Journal of Internal Medicine|December 1, 2019
A new approach for anemia in kidney diseasePiergiorgio Messa, Maria Domenica Cappellini
Therapeutics and Clinical Risk Management|November 10, 2009
Update on the use of deferasirox in the management of iron overloadAli Taher, Maria Domenica Cappellini
Human Genetics|June 29, 2007
Gene symbol: HBDChiara Refaldi, Maria Domenica Cappellini
Annual Review of Medicine|July 28, 2009
Oral iron chelatorsMaria Domenica Cappellini, Paolo Pattoneri
Blood|September 13, 2018
How I manage medical complications of β-thalassemia in adultsAli T Taher, Maria Domenica Cappellini
Pageof 32